Effect of calmodulin on Ca2+-induced Ca2+ release of skeletal muscle from mutant mice expressing either ryanodine receptor type 1 or type 3

Pflugers Arch. 1998 Dec;437(1):43-8. doi: 10.1007/s004240050744.

Abstract

We analyzed the effects of calmodulin (CaM) on Ca2+-induced Ca2+ release (CICR) in mouse skeletal muscle cells expressing only ryanodine receptor type 1 (RyR-1) or type 3 (RyR-3) following targeted disruption of one of the RyR genes. Under Mg2+-free conditions, CaM potentiated CICR via RyR-3 at low Ca2+ concentrations (pCa>/=6) but inhibited CICR at high Ca2+ concentrations (pCa</=5). On the other hand, CaM potentiated CICR via RyR-1 between pCa 7 and pCa 5. Greater concentrations of CaM were required for potentiation of CICR at pCa 6 than for the inhibition at pCa 5 in the RyR-3-expressing cells. Similarly, higher concentrations of CaM were required for the potentiation of CICR via RyR-1 at pCa 6 than potentiation at pCa 5. In the presence of Mg2+ and beta,gamma-methyleneadenosine 5'-trisphosphate (AMPOPCP), the same differential effects of CaM on the CICR via the different subtypes of RyR were observed. These data suggest that multiple CaM-binding sites are involved in the differential effects on RyR-1 and RyR-3. These effects of CaM are important for the evaluation of the physiological roles of RyRs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine Nucleotides / pharmacology
  • Animals
  • Animals, Newborn
  • Calcium / metabolism*
  • Calcium / pharmacology*
  • Calmodulin / pharmacology*
  • Gene Expression
  • Magnesium / pharmacology
  • Mice
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / metabolism*
  • Mutation*
  • Ryanodine Receptor Calcium Release Channel / genetics*

Substances

  • Adenine Nucleotides
  • Calmodulin
  • Ryanodine Receptor Calcium Release Channel
  • Magnesium
  • Calcium